Aeterna Zentaris (AEZS +1.8%) gains after saying it's signed an exclusive agreement for the...

|By:, SA News Editor

Aeterna Zentaris (AEZS +1.8%) gains after saying it's signed an exclusive agreement for the registration and marketing of perifosine in the Middle East and North Africa with Hikma Pharmaceuticals (HKMPY.PK).